Utilizing the cPLA2 specific inhibitor PLA-695, we determined if cPLA2 inhibition radiosensitizes non small cell lung cancer (NSCLC) cells and tumors. This evidence concerns the gene PLA2G4A and non-small cell lung carcinoma.